Abatacept management during the perioperative period in patients with rheumatoid arthritis: Report on eight orthopaedic procedures

Modern Rheumatology

Volumn 24, Issue 3, 2014, Pages 544-545

  Nishida, Keiichiro ^a   Nasu, Yoshihisa ^b   Hashizume, Kenzo ^a   Nakahara, Ryuichi ^a   Ozawa, Masatsugu ^a   Harada, Ryozo ^a   Machida, Takahiro ^a   Ozaki, Toshihumi ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b Kurashiki Municipal Hospital   (Japan)

Author keywords

Abatacept; Delayed wound healing; Orthopaedic surgery; Rheumatoid arthritis; Surgical site infection

Indexed keywords

ABATACEPT; DISEASE MODIFYING ANTIRHEUMATIC DRUG; METHOTREXATE; PREDNISOLONE; ANTIBODY CONJUGATE; ANTIRHEUMATIC AGENT;

ADULT; AGED; ARTHROPLASTY; ARTICLE; CLINICAL ARTICLE; DEVICE REMOVAL; FEMALE; FINGER ARTHROPLASTY; HUMAN; MEDICAL RECORD REVIEW; METATARSAL OSTEOTOMY; MIDDLE AGED; MULTICENTER STUDY (TOPIC); ORTHOPEDIC SURGERY; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYNOVECTOMY; TOTAL KNEE REPLACEMENT; TREATMENT DURATION; ARTHRITIS, RHEUMATOID; CASE REPORT; DRUG ADMINISTRATION;

ADULT; AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; IMMUNOCONJUGATES; MIDDLE AGED; ORTHOPEDIC PROCEDURES; PERIOPERATIVE PERIOD;

EID: 84900454094     PISSN: 14397595     EISSN: 14397609     Source Type: Journal    
DOI: 10.3109/14397595.2013.874758     Document Type: Article

References (8)

1. Maxwell L J Singh J A. Abatacept for rheumatoid arthritis: Cochrane systematic review. J. Rheumatol. 2010; 37 (2): 234-45
2. Keith M P. Perspectives on rheumatoid arthritis for the orthopedic surgeon: Overview of non-Tumor necrosis factor biologic drugs and perioperative management. Am J Orthop (Belle Mead NJ). 2011 ; 40 (12): E272-5
3. Matsubara T Yamana S Tohma S Takeuchi T Kondo H Kohsaka H et al. Tolerability and effi cacy of abatacept in Japanese patients with rheumatoid arthritis: Phase I study. Mod Rheumatol. 2012. doi:10.1007/s10165-012-0722-x
4. Takahashi N Kojima T Terabe K Kaneko A Kida D Hirano Y et al. Clinical effi cacy of abatacept in Japanese rheumatoid arthritis patients. Mod Rheumatol. 2012. doi: 10.1007/s10165-012-0760-4
5. Takeuchi T Matsubara T Nitobe T Suematsu E Ohta S Honjo S et al. Phase II dose-response study of abatacept in Japanese patients with active rheumatoid arthritis with an inadequate response to methotrexate. Mod Rheumatol. 2012. doi:10.1007/s10165-012-0668-z
6. Pham T. Bachelez H. Berthelot JM. Blacher J. Claudepierre P Constantin A. Abatacept therapy and safety management. Jt Bone Spine. 2012; 79 (Suppl 1): 3-84
7. Salliot C. Dougados M. Gossec L. Risk of serious infections during rituximab abatacept and anakinra treatments for rheumatoid arthritis: Meta-Analyses of randomised placebo-controlled trials. Ann Rheum Dis. 2009; 68 (1): 25-32
8. Gottenberg J. Ravaud P. Bardin T. Cacoub P. Cantagrel A. Combe B et al. Predictive risk factors of severe infections in RA patients treated with abatacept in real life: Results from the Orencia and Rheumatoid Arthritis (ORA) registry. Arthr Rheum. 2010; 62 (10S): 169